JAZZ vs SCSC · P/E 1988, rev $2.28B vs P/E 15, rev $3.23B
Jazz Pharmaceuticals PLC (JAZZ) versus ScanSource Inc (SCSC) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
ScanSource Inc (SCSC) is a electronics & computer distribution company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported SCSC revenue for 2026-06-30 was $3.23B. Net income was $78.9M. Revenue was up 6.1% from 2025-06-30 to 2026-06-30. SCSC currently screens at market cap $988.6M and trailing P/E 14.8.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. SCSC currently screens at market cap $988.6M and trailing P/E 14.8.
Not investment advice. Open the JAZZ and SCSC stock pages for the full models.
Not investment advice.